The National Institute of Diabetes and Digestive and Kidney Diseases     HHS

Researchers have begun a clinical study of oral insulin to prevent or delay type 1 diabetes in at-risk people. Type 1 Diabetes is being studied in more than 100 medical centers across the United States, Canada, Europe, and Australia.